Prominent changes in the gut microbiota (referred to as "dysbiosis") play a key role in the development of allergic disorders, but the underlying mechanisms remain unknown. Study of the delayedtype hypersensitivity (DTH) response in mice contributed to our knowledge of the pathophysiology of human allergic contact dermatitis. Here we report a negative regulatory role of the RIG-I-like receptor adaptor mitochondrial antiviral signaling (MAVS) on DTH bymodulating gut bacterial ecology. Cohousing and fecal transplantation experiments revealed that the dysbiotic microbiota of Mavs-/-mice conferred a proallergic phenotype that is communicable to wild-type mice. DTH sensitization coincided with increased intestinal permeability and bacterial translocation within lymphoid organs that enhanced DTH severity. Collectively, we unveiled an unexpected impact of RIG-I-like signaling on the gut microbiota with consequences on allergic skin disease outcome. Primarily, these data indicate that manipulating the gut microbiota may help in the development of therapeutic strategies for the treatment of human allergic skin pathologies.
CITATION STYLE
Plantamura, E., Dzutsev, A., Chamaillard, M., Djebalia, S., Moudombi, L., Boucinha, L., … Michallet, M. C. (2018). MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype marie-cecile.michallet@lyon.unicancer.fr. Proceedings of the National Academy of Sciences of the United States of America, 115(41), 10404–10409. https://doi.org/10.1073/pnas.1722372115
Mendeley helps you to discover research relevant for your work.